Filter By
- Agency-Based Community Benefit (ABCB)
- Behavioral Health Reform and Investment Act Senate Bill 3 (SB3)
- Beneficiary Advisory Council (BAC)
- Child Support Services
- DDSD Provider Enrollment & Relations
- Electronic Benefits Transfer (EBT)
- Employee Abuse Registry (EAR)
- Fraud, Waste, & Abuse
- (-) Health Care Consolidation Oversight Act
- Intermediate Care Facility for Individuals with Intellectual Disabilities (ICF/IID)
- (-) Justice-involved Utilization of State Transitioned Healthcare (JUST Health)
- Marketplace Affordability Programs
- Medicaid Transition Premium Relief Program
- National Guard Premium Assistance
- New Mexico Medicaid Estate Recovery Program
- Ordering, Referring, Prescribing Provider (ORP)
- Refugee Resettlement Program
- Rural Health Care Delivery Fund
- Small Business Health Insurance Premium Relief Initiative
- SNAP Quality Control Reviews
- State Employee Premium Assistance Program
- Sun Bucks
- Supplemental Nutrition Assistance Program (SNAP)
- Turquoise Care
The authority may retain actuaries, accountants, attorneys or other professionals who are qualified and have expertise in the type of transaction under review as necessary to assist the authority in conducting its review of the proposed transaction.
The parties submitting the information for a proposed transaction shall pay the authority reasonable cost and expenses incurred by the authority in the performance of the authority’s duties pursuant to the Health Care Consolidation Oversight Act for cost associated with the authority’s contracts with experts, unless determined otherwise by the secretary.
There may be administrative fines incurred for transactions that are effectuated prior to approval by the Health Care Authority. These fines range from $5,000 per instance of violation to a maximum of $15,000 per day. Money collected from these fines will be deposited to the state treasury to credit of the current school fund as provided in Article 12, Section 4 of the constitution of New Mexico.
There are also Whistleblower fines ranging from $10,000 per violation and not to exceed $100,000 per violation.
Entry into a binding agreement before a transaction is effectuated is not a violation of the Health Care Consolidation Act if the transaction remains subject to regulatory review and approval.
The parties shall not effectuate a transaction without the written approval of the secretary.
The submitting party shall notify the authority in a form and manner prescribed by the authority when a transition is effectuated. Once notified, the process for licensing or ownership change will be followed as mandated by the state.
Long-acting injectable MAT (e.g., Buprenorphine) is covered by Medicaid and therefore reimbursable under JUST Health Plus. All MAT drugs are preferred regardless of brand. Please refer to the Preferred Drug List (PDL).
MAT medications, up to a 30-day supply, must be provided in-hand upon release as clinically appropriate. HCA expects prescribers to use their clinical judgement when determining the appropriate amount of medication to provide upon release. The provision of long-acting injectable MAT prior to release may fulfill the requirement for the (up to) 30-day supply of medications upon release.
JUST Health Plus covers initiation and maintenance of HepC treatment under Service Level 2. Providing maintenance of HepC treatment is allowable under the 1115 demonstration (JUST Health Plus) as facilities ramp-up treatment capacity, but the goal is to test and treat HepC as clinically appropriate. Facilities are expected to offer treatment when testing for HepC (as clinically indicated).